AlphaYou
Overview
Key stats
Fundamentals Sep 10- Open
- $327.55
- 52-wk high
- $375.33
- High
- $330.00
- 52-wk low
- $243.78
- Low
- $323.05
- Prev close
- $330.95
- Mkt cap
- $61.70B
- P/E
- 24.0x
- Volume
- 2.20M
- Fwd P/E
- 16.3x
- Beta
- 0.57
- Div yield
- 0.72%
- P/S
- 0.2x
- P/B
- 20.3x
- Profit margin
- +0.8%
- Op margin
- +1.4%
- ROE
- +96.9%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsSmart money
8 funds hold a position and insiders have been net buying.
What funds are doing
Activist stakes, short interest & more
Earnings
Earnings came in 2.5% above what analysts expected.
Earnings per share
$4.37 expected
Revenue
$84.15B expected
GAAP EPS was $3.94 and adjusted EPS was $4.48. The adjusted figure is comparable to consensus.
FY2026 guidance
$4.00 to $6.00
No comparable estimate
What the street expects next
EPS expected
$4.50 to $4.62
Revenue expected
10 analysts
Last 30 days
Analysts cutting estimates
Estimate drift
Change in 30 days
What the company said
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $83.73B | $85.93B | $78.36B | $84.75B |
| Cost of what it sold | $81.13B | $83.12B | $75.03B | $81.15B |
| Gross profit | $2.60B | $2.81B | $3.32B | $3.61B |
| What it spent | ||||
| Sales and admin | $1.75B | $1.80B | $1.98B | $2.13B |
| Other operating costs | — | — | — | $354.6M |
| Total operating expenses | $1.75B | $1.80B | $1.98B | $2.49B |
| What was left | ||||
| Operating profit | $854.6M | $1.02B | $1.34B | $1.12B |
| Interest on debt | $109.4M | $93.4M | $154.3M | $140.7M |
| Profit before tax | -$187.0M | $708.6M | $2.09B | $996.4M |
| Tax | $146.0M | $142.5M | $459.0M | $219.7M |
| Net profit | -$339.7M | $559.6M | $1.64B | $763.5M |
| EBITDA | $183.3M | $1.04B | $2.50B | $1.41B |
Technicals
Price structure
This stock is in a strong uptrend.
Trend
Strong uptrend
100 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage is mixed
Tone of tracked coverage
Oak Ridge Investments LLC Decreases Position in Amazon.com, Inc. $AMZN
Leans bullishSep 7McKesson Bets $2.25 Billion More on Oncology With Precision Medicine Buy
NeutralSep 6Vest Financial LLC Has $41.44 Million Stake in Amazon.com, Inc. $AMZN
Leans bullishSep 6Here's Why You Should Retain Cencora Stock in Your Portfolio for Now
Leans bullishSep 4AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?
NeutralSep 4Cencora (COR) Unveils Cell And Gene Therapy Enablement Service
Leans bullishSep 4Former Cencora (NYSE: COR) leader lines up another stock sale
NeutralSep 4Cencora Inc. stock underperforms Friday when compared to competitors
Leans bearishSep 4
Macro
33 macro signals shaping COR right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results